20 research outputs found
Features of the interrelationships of some molecular parameters of cervical epithelium cells with biological characteristics of tumor cells in the process of cervical carcinogenesis
Background. Despite the known trigger and identified risk factors, the screening program developed, many aspects of the pathogenesis of cervical cancer are still being studied. In particular, recently in the literature there are data on the participation of short-chain fatty acids in the tumor process. The aim of the study was to perform a correlation analysis of the level of TNF-A., its soluble sTNF-RI receptor, the spectrum of SCFA and some biological parameters (apoptosis, necrosis, proliferation, cell cycle) in the exocervical cells during dys- and neoplastic transformation. Materials and methods: the laboratory data obtained by us earlier were used to perform the Spearman correlation analysis. The groups of research: IA - the focus of the pre-tumor lesion of exocervix; IB - paradysplastic cells; IIA - locus of cervical cancer; IIB - paraneoplastic cells. Results. The correlation relationships between the parameters studied were multidirectional, determined by the state of the cell (healthy, dysplastic, malignant) and varied within one study, depending on the location in relation to the pathological focus. Conclusions. The revealed interrelations are important for expanding the already available information on cervical carcinogenesis, for discovery of new diagnostic methods and treatment of cervical neoplasia. Summarizing, it is possible to judge the presence of pathogenetic relationships between the processes of cervical carcinogenesis (proliferation, apoptosis, necrosis, modulation of the phases of the cell cycle), the level of short-chain fatty acids and cytokine production at the local level
Acute kidney injury in patients with pneumonia with A/H1N1 influenza
Background. A critical condition of any genesis may be accompanied by the development of multiple organ failure, one of the manifestations of which is acute renal injury. Often, the process is subclinical in nature and the Β«classicalΒ» approaches to diagnose renal damage by creatinine concentration, urea level and assessment of glomerular filtration rate may not fully reflect the degree of impaired renal function, while acute kidney injury is a well-known predictor of high hospital mortality among critically ill patients.Aims. The purpose of this study was to assess functional state of the kidneysby determining the serum concentration of the markers of kidney injuryΒ NGAL and Cystatin C in patients with pneumonia associated with influenza A/H1N1.Materials and methods. 85 patients with pneumonia associated with influenza A/H1N1 were examined, 30 patients with severe pneumonia, 55 with non-severe pneumonia. The control group was formed by 15 healthy donors. The serum concentration of NGAL and Cystatin C molecules was determined by flow cytometry on a Beckman Coulter analyzer (USA), using a Human Immune Checkpoint Panel 1 multiplex assay kit (Biolegend, USA). The glomerular filtration rate was calculated using the CKD-EPI formula.Results. It was found that in patients with severe pneumonia with the influenza A/H1N1, the concentration of NGAL increased 3.8 times compared with the control group, the concentration of Cystatin C increased 1.4 times, the glomerular filtration rate did not change.Conclusion. Timely diagnosis of subclinical kidney injury makes it possible toΒ objectify the severity of the condition, make adjustments to therapy, which can help to an increase in the survival rate of critically ill patients
ΠΠΠΠ§ΠΠΠΠ Π€ΠΠΠ’ΠΠ ΠΠ Π ΠΠ‘Π’Π Π ΠΠΠΠΠΠΠΠ’ΠΠΠ¬ΠΠΠ ΠΠΠΠΠΠΠ‘Π’ΠΠΠ Π ΠΠΠ Π’ΠΠΠ‘Π’ΠΠ ΠΠΠ¨ΠΠ
Β Objective: to determine the level of growth factors in the blood serum of patients with left-sided colon cancer and to assess the feasibility of using these findings in the tumor detection.Material and Methods. The study group included 63 patients aged 20 to 75 years who underwent surgery for left-sided colon adenocarcinoma (descending, sigmoid, rectosigmoid) with stage i (t1β2n0m0), ii (t3β4an0m0), and iii (t1β2n1m0). Only 5 patients developed metastases in one regional lymph node. The remaining patients had no regional metastases. In all patients, before hospitalization, the tumor was confirmed by colonoscopy followed by histological examination. The group of comparison consisted of 25 patients with chronic hemorrhoids without exacerbation, who underwent colonoscopy. In patients of the study group, blood tests were drawn on the day of surgery before its starting. In patients of the comparison group, blood was taken after excluding colon cancer (after colonoscopy). Blood tests were carried out using a test system (Biolegend): multiplex set for determining growth factors (angiopoietin-2, (ang-2), egf, epo, FGF-basic, G-csf, GM-csf, HGF, M-csf, pdgf-aa, pdgf-BB, scf, tgf-Ξ±, vegf).Results. In cancer patients, the levels of egf, HGF, M-csf, pdgf-aa, and pdgf-BB were several times higher than in the control group (p <0.05). The level of pdgf-aa was 10 times higher in cancer patients than in controls. In addition to quantitative changes, statistically significant differences were observed between the vegf level and sex of the patients; angio protein-2, G-csf, epo, M-csf, pdgf-aa, pdgf-BB, vegf levels and the age of the patients; tgf-Ξ±, HGF levels and the histological grade of the tumor.Conclusion. It was found that changes in the level of biologically active substances that occur in colon cancer can serve as additional diagnostic markers for cancer detection.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ ΡΡΠΎΠ²Π΅Π½Ρ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΠ°ΠΊΠΎΠΌ Π»Π΅Π²ΠΎΠΉ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Ρ ΡΠΎΠ»ΡΡΠΎΠΉ ΠΊΠΈΡΠΊΠΈ ΠΈ ΠΎΡΠ΅Π½ΠΈΡΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ ΡΡΠΈΡ
Π΄Π°Π½Π½ΡΡ
Π² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°.ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΎΡΠ½ΠΎΠ²Π½ΡΡ Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΎ 63 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ ΠΎΡ 20 Π΄ΠΎ 75 Π»Π΅Ρ, ΠΎΠΏΠ΅ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΏΠΎ ΠΏΠΎΠ²ΠΎΠ΄Ρ ΡΠ°ΠΊΠ° (Π°Π΄Π΅Π½ΠΎΠΊΠ°ΡΡΠΈΠ½ΠΎΠΌΡ) Π»Π΅Π²ΠΎΠΉ ΠΏΠΎΠ»ΠΎΠ²ΠΈΠ½Ρ ΠΎΠ±ΠΎΠ΄ΠΎΡΠ½ΠΎΠΉ ΠΊΠΈΡΠΊΠΈ (Π½ΠΈΡΡ
ΠΎΠ΄ΡΡΠΈΠΉ, ΡΠΈΠ³ΠΌΠΎΠ²ΠΈΠ΄Π½ΡΠΉ, ΡΠ΅ΠΊΡΠΎΡΠΈΠ³ΠΌΠΎΠΈΠ΄Π½ΡΠΉ ΠΎΡΠ΄Π΅Π»Ρ) i (t1β-2n0M0), ii (t3β4Π°n0M00 ΠΈ iii (t1β2n1M0) ΡΡΠ°Π΄ΠΈΠΈ. Π£ 5 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π±ΡΠ» Π²ΡΡΠ²Π»Π΅Π½ ΠΌΠ΅ΡΠ°ΡΡΠ°Π· Π² ΠΎΠ΄Π½ΠΎΠΌ ΡΠ΅Π³ΠΈΠΎΠ½Π°ΡΠ½ΠΎΠΌ Π»ΠΈΠΌΡΠΎΡΠ·Π»Π΅. ΠΡΡΠ°Π»ΡΠ½ΡΠ΅ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Π±ΡΠ»ΠΈ Π±Π΅Π· ΡΠ΅Π³ΠΈΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠ°ΡΡΠ°Π·ΠΈΡΠΎΠ²Π°Π½ΠΈΡ. Π£ Π²ΡΠ΅Ρ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π΄ΠΎ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΎΠΏΡΡ
ΠΎΠ»Ρ Π±ΡΠ»Π° ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π° ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²ΠΎΠΌ ΠΊΠΎΠ»ΠΎΠ½ΠΎΡΠΊΠΎΠΏΠΈΠΈ Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠΈΠΌ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ. ΠΡΡΠΏΠΏΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Π² ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅ 25 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΡ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π³Π΅ΠΌΠΎΡΡΠΎΠ΅ΠΌ Π²Π½Π΅ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΡ, ΠΊΠΎΡΠΎΡΡΠΌ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»Π°ΡΡ ΠΊΠΎΠ»ΠΎΠ½ΠΎΡΠΊΠΎΠΏΠΈΡ. ΠΠ°Π±ΠΎΡ ΠΊΡΠΎΠ²ΠΈ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ»ΡΡ Π² Π΄Π΅Π½Ρ ΠΎΠΏΠ΅ΡΠ°ΡΠΈΠΈ Π΄ΠΎ Π΅Π΅ Π½Π°ΡΠ°Π»Π°. Π£ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π³ΡΡΠΏΠΏΡ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ ΠΊΡΠΎΠ²Ρ Π±ΡΠ°Π»ΠΈ ΠΏΠΎΡΠ»Π΅ ΠΈΡΠΊΠ»ΡΡΠ΅Π½ΠΈΡ ΡΠ°ΠΊΠ° ΡΠΎΠ»ΡΡΠΎΠΉ ΠΊΠΈΡΠΊΠΈ (ΠΏΠΎΡΠ»Π΅ ΠΊΠΎΠ»ΠΎΠ½ΠΎΡΠΊΠΎΠΏΠΈΠΈ). ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ»ΠΎΡΡ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ΅ΡΡ-ΡΠΈΡΡΠ΅ΠΌΡ (Biolegend): ΠΌΡΠ»ΡΡΠΈΠΏΠ»Π΅ΠΊΡΠ½ΡΠΉ Π½Π°Π±ΠΎΡ Π΄Π»Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΡ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΡΠΎΡΡΠ° (angiopoietin-2, (ang-2), eGF, ePO, FGF-basic, G-CsF, GM-CsF, HGF, M-CsF, PdGF-aa, PdGF-BB, sCF, tGF-Ξ±, VeGF).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π ΡΡΠ΅Π΄Π½Π΅ΠΌ Ρ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΡΡΠΎΠ²Π΅Π½Ρ ΡΠ°ΠΊΠΈΡ
ΡΡΠ°Π²Π½ΠΈΠ²Π°Π΅ΠΌΡΡ
Π²Π΅ΡΠ΅ΡΡΠ², ΠΊΠ°ΠΊ eGF, HGF, M-CsF, PdGF-aa, PdGF-ΠΠ, Π±ΡΠ» Π²ΡΡΠ΅, ΡΠ΅ΠΌ Π² ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅, Π² Π½Π΅ΡΠΊΠΎΠ»ΡΠΊΠΎ ΡΠ°Π·, ΡΡΠΎ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Β Π·Π½Π°ΡΠΈΠΌΡΠΌ (Ρ<0,05). ΠΡΠΎΠ±Π΅Π½Π½ΠΎ ΡΡΠΊΠΎ Π²ΡΡΠ°ΠΆΠ΅Π½Π½Π°Ρ ΡΠ°Π·Π½ΠΈΡΠ° (Π±ΠΎΠ»Π΅Π΅ ΡΠ΅ΠΌ Π² 10 ΡΠ°Π·) ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΠΏΠΎ ΡΡΠΎΠ²Π½Ρ PdGF-aa. ΠΊΡΠΎΠΌΠ΅ ΠΎΠ±ΡΠΈΡ
ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ, ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½Π° ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠ°Ρ Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΡ ΡΡΠΎΠ²Π½Ρ ΠΈΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΡ
Π²Π΅ΡΠ΅ΡΡΠ²: VeGF β Ρ ΠΏΠΎΠ»ΠΎΠΌ; angioprotein-2, G-CsF, ePO, M-CsF, PdGFaa, PdGF-ΠΠ, VeGF β Ρ Β Π²ΠΎΠ·ΡΠ°ΡΡΠΎΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ°; tGF-Ξ±, HGF β ΡΠΎ ΡΡΠ΅ΠΏΠ΅Π½ΡΡ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΠΈ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠΎΠ²Π½Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΡ
Π²Π΅ΡΠ΅ΡΡΠ², Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡΠΈΠ΅ ΠΏΡΠΈ ΡΠ°ΠΊΠ΅ ΡΠΎΠ»ΡΡΠΎΠΉ ΠΊΠΈΡΠΊΠΈ, ΠΌΠΎΠ³ΡΡ ΡΠ»ΡΠΆΠΈΡΡ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΌ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠΌ ΠΏΡΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ
ΠΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠΈΡΡΠ΅ΠΌΡ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° PD-1/PD-L1/PD-L2 Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡΠΌΠΈ Π½Π° ΡΠΎΠ½Π΅ Π³ΡΠΈΠΏΠΏΠ° A/H1N1
Systemic inο¬ammation is an integral pathophysiological component of many critical illnesses. The systemic inο¬ammatory response is based on a cascade of interactions leading to hypercytokinemia and, as a consequence, multiple organ failure, which is one of the main causes of mortality in intensive care units.Aim of the study. To evaluate the activity of the negative regulation system of T-cell response by determining the plasma levels of PD-1, PD-L1 and PD-L2 molecules in pneumonia patients with inο¬uenza A (H1N1).Materials and methods. 85 patients with pneumonia and underlying inο¬uenza A (H1N1) were examined. Among them there were 30 patients with severe pneumonia, and 55 patients with non-severe pneumonia. Plasma levels of PD-1, PD-L1, PD-L2 molecules was determined by ο¬ow cytoο¬uorometry method.Results. In patients with severe pneumonia and underlying inο¬uenza A (H1N1), the plasma level of PD-1 receptor increased 4.6-fold, while the concentration of its ligands PD-L1 and PD-L2 increased 10.6 and 2.2-fold, respectively.Conclusion. Signiο¬cant increase in levels of PD-1 and its ligands PD-L1 and PD-L2 in patients with pneumonia and underlying inο¬uenza A (H1N1) indicates the involvement of negative regulation system of T-cell response in the cascade of immunological reactions and is associated with the severe disease. Possible correction of immune reactions realized through PD-1/PD-L1/PD-L2 complex in critically ill patients is a promising research avenue.Π‘ΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ΅ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ Π½Π΅ΠΎΡΡΠ΅ΠΌΠ»Π΅ΠΌΠΎΠΉ ΠΏΠ°ΡΠΎΡΠΈΠ·ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΎΡΡΠ°Π²Π»ΡΡΡΠ΅ΠΉ ΠΌΠ½ΠΎΠ³ΠΈΡ
ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠΎΡΡΠΎΡΠ½ΠΈΠΉ. Π ΠΎΡΠ½ΠΎΠ²Π΅ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ³ΠΎ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° Π»Π΅ΠΆΠΈΡ ΠΊΠ°ΡΠΊΠ°Π΄ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠΉ, ΠΏΡΠΈΠ²ΠΎΠ΄ΡΡΠΈΠΉ ΠΊ Π³ΠΈΠΏΠ΅ΡΡΠΈΡΠΎΠΊΠΈΠ½Π΅ΠΌΠΈΠΈ, ΠΈ, ΠΊΠ°ΠΊ ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅, ΠΊ ΠΏΠΎΠ»ΠΈΠΎΡΠ³Π°Π½Π½ΠΎΠΉ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΠΈ, ΠΊΠΎΡΠΎΡΠ°Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
ΠΏΡΠΈΡΠΈΠ½ Π»Π΅ΡΠ°Π»ΡΠ½ΠΎΡΡΠΈ Π² ΠΎΡΠ΄Π΅Π»Π΅Π½ΠΈΡΡ
ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ.Π¦Π΅Π»Ρ ΡΠ°Π±ΠΎΡΡ. ΠΡΠ΅Π½ΠΈΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠΈΡΡΠ΅ΠΌΡ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ°, ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΠ² ΠΏΠ»Π°Π·ΠΌΠ΅Π½Π½ΡΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ» PD-1, PD-L1 ΠΈ PD-L2 Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΡΠΌΠΈ Π½Π° ΡΠΎΠ½Π΅ Π³ΡΠΈΠΏΠΏΠ° A/H1N1.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ 85 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ Π½Π° ΡΠΎΠ½Π΅ Π³ΡΠΈΠΏΠΏΠ° A/H1N1. ΠΠ· Π½ΠΈΡ
30 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΡΠΆΠ΅Π»ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ, 55 β Ρ Π½Π΅ΡΡΠΆΠ΅Π»ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ. ΠΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΡΠΎΡΠ»ΡΠΎΠΌΠ΅ΡΡΠΈΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΏΠ»Π°Π·ΠΌΠ΅Π½Π½ΡΡ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΠΌΠΎΠ»Π΅ΠΊΡΠ» PD-1, PD-L1, PD-L2.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ΡΡΠ°Π½ΠΎΠ²ΠΈΠ»ΠΈ, ΡΡΠΎ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΡΡΠΆΠ΅Π»ΠΎΠΉ ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ Π½Π° ΡΠΎΠ½Π΅ Π³ΡΠΈΠΏΠΏΠ° A/H1N1 ΠΏΠ»Π°Π·ΠΌΠ΅Π½Π½Π°Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ° PD-1 ΠΏΠΎΠ²ΡΡΠ°Π»Π°ΡΡ Π² 4,6 ΡΠ°Π·Π°, ΠΏΡΠΈ ΡΡΠΎΠΌ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΡ Π΅Π³ΠΎ Π»ΠΈΠ³Π°Π½Π΄ΠΎΠ² PD-L1 ΠΈ PD-L2 ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π»Π°ΡΡ Π² 10,6 ΠΈ Π² 2,2 ΡΠ°Π·Π°, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΠΎ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. Π‘ΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π½Π°ΡΠΈΠΌΠΎΠ΅ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ PD-1 ΠΈ Π΅Π³ΠΎ Π»ΠΈΠ³Π°Π½Π΄ΠΎΠ² PD-L1 ΠΈ PD-L2 Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΏΠ½Π΅Π²ΠΌΠΎΠ½ΠΈΠ΅ΠΉ Π½Π° ΡΠΎΠ½Π΅ Π³ΡΠΈΠΏΠΏΠ° A/H1N1 ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎ Π²ΠΎΠ²Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π² ΠΊΠ°ΡΠΊΠ°Π΄ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ ΡΠΈΡΡΠ΅ΠΌΡ Π½Π΅Π³Π°ΡΠΈΠ²Π½ΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ Π’-ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ° ΠΈ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½ΠΎ Ρ ΡΡΠΆΠ΅ΡΡΡΡ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ. ΠΠΎΠ·ΠΌΠΎΠΆΠ½Π°Ρ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ ΠΈΠΌΠΌΡΠ½Π½ΡΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ, ΡΠ΅Π°Π»ΠΈΠ·ΡΠ΅ΠΌΡΡ
ΡΠ΅ΡΠ΅Π· ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡ PD-1/PD-L1/PD-L2 Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΠΊΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΡΠΎΡΡΠΎΡΠ½ΠΈΠΈ β ΡΡΠΎ ΠΏΠ΅ΡΡΠΏΠ΅ΠΊΡΠΈΠ²Π½ΠΎΠ΅ Π½Π°ΡΡΠ½ΠΎΠ΅ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠ΅
ΠΠΠΠ―ΠΠΠ ΠΠ ΠΠΠΠΠΠΠ’Π ΠΠ Π‘ΠΠΠΠ’Π ΠΠ«Π‘Π¨ΠΠ₯ ΠΠΠ ΠΠ«Π₯ ΠΠΠ‘ΠΠΠ’ Π ΠΠΠΠ’ΠΠΠ₯ Π¨ΠΠΠΠ ΠΠΠ’ΠΠ ΠΠ Π ΠΠΠ‘- Π ΠΠΠΠΠΠΠ‘Π’ΠΠ§ΠΠ‘ΠΠΠ Π’Π ΠΠΠ‘Π€ΠΠ ΠΠΠ¦ΠΠ
Background. Metabolic reprogramming of tumor cells is one of the leading links in carcinogenesis. The objective to confirm the hypothesis of a propionate pathway for the synthesis of long-chain acids with an odd number of carbon atoms in cervical cancer.Materials and methods. As samples for the study were biopsies of the colli uteri, from which a suspension of tumor cells was obtained (20 β cervical cancer, 20 β cervical intraepithelial neoplasia III grade, 18 β endocervical scraping from healthy women). The spectrum of fatty acids (FA) was analyzed before, after 24 hours incubation without and with 50 ΞΌmol/l propionic acid by the gas chromatography method.Results. Metabolism of FA is multidirectional in different locus in cervical cancer. In the locus of cervical cancer, most likely, there is a propionic pathway for the synthesis of FA using palmitate. In cervical intraepithelial neoplasia III grade, the metabolism of FA is another. Palmitic acid was used for synthesis stearate, which was metabolized to oleic acid.Π‘onclusion. The specificity of biochemical changes within one organ and one pathology has been revealed, which reflects the stage-by-stage development of the oncological process.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. ΠΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΏΠ΅ΡΠ΅ΠΏΡΠΎΠ³ΡΠ°ΠΌΠΌΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Π²Π΅Π΄ΡΡΠΈΡ
Π·Π²Π΅Π½ΡΠ΅Π² ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π΅Π·Π°. Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠ΄ΠΈΡΡ Π³ΠΈΠΏΠΎΡΠ΅Π·Ρ ΠΏΡΠΎΠΏΠΈΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΡΠΈ ΡΠΈΠ½ΡΠ΅Π·Π° Π²ΡΡΡΠΈΡ
ΠΆΠΈΡΠ½ΡΡ
ΠΊΠΈΡΠ»ΠΎΡ (ΠΠΠ) Ρ Π½Π΅ΡΠ΅ΡΠ½ΡΠΌ ΡΠΈΡΠ»ΠΎΠΌ Π°ΡΠΎΠΌΠΎΠ² ΡΠ³Π»Π΅ΡΠΎΠ΄Π° ΠΏΡΠΈ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΌ ΡΠ°ΠΊΠ΅.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² Π΄Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΠΎΡΠ»ΡΠΆΠΈΠ»ΠΈ Π±ΠΈΠΎΠΏΡΠ°ΡΡ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ, ΠΈΠ· ΠΊΠΎΡΠΎΡΡΡ
Π²ΡΠ΄Π΅Π»ΡΠ»ΠΈ ΡΡΡΠΏΠ΅Π½Π·ΠΈΡ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ (20 β ΡΠ°ΠΊ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ, 20 β ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½Π°Ρ ΠΈΠ½ΡΡΠ°ΡΠΏΠΈΡΠ΅Π»ΠΈΠ°Π»ΡΠ½Π°Ρ Π½Π΅ΠΎΠΏΠ»Π°Π·ΠΈΡ, 18 β ΡΠ½Π΄ΠΎΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΡΠΉ ΡΠΎΡΠΊΠΎΠ± ΠΎΡ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
ΠΆΠ΅Π½ΡΠΈΠ½). Π‘ΠΏΠ΅ΠΊΡΡ ΠΠΠ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΠΈ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ 24-ΡΠ°ΡΠΎΠ²ΠΎΠΉ ΠΈΠ½ΠΊΡΠ±Π°ΡΠΈΠΈ Ρ 50 ΠΌΠΊΠΌΠΎΠ»Ρ/Π» ΠΏΡΠΎΠΏΠΈΠΎΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ ΠΈ Π±Π΅Π· Π½Π΅Π΅ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΠΌΠ΅ΡΠΎΠ΄Π° Π³Π°Π·ΠΎΠ²ΠΎΠΉ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΠΈ.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΠΈ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΡΡΠ°Π½ΡΡΠΎΡΠΌΠ°ΡΠΈΠΈ ΡΠΏΠΈΡΠ΅Π»ΠΈΡ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΡΠ³Π°Π½Π° ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ ΠΠΠ ΡΠ°Π·Π½ΠΎΠ½Π°ΠΏΡΠ°Π²Π»Π΅Π½. Π Π»ΠΎΠΊΡΡΠ΅ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ°ΠΊΠ°, Π²Π΅ΡΠΎΡΡΠ½Π΅Π΅ Π²ΡΠ΅Π³ΠΎ, ΠΈΠΌΠ΅Π΅Ρ ΠΌΠ΅ΡΡΠΎ ΠΏΡΠΎΠΏΠΈΠΎΠ½Π°ΡΠ½ΡΠΉ ΠΏΡΡΡ ΡΠΈΠ½ΡΠ΅Π·Π° ΠΠΠ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΏΠ°Π»ΡΠΌΠΈΡΠ°ΡΠ°. ΠΡΠΈ ΡΡΠΆΠ΅Π»ΠΎΠΉ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΉ Π΄ΠΈΡΠΏΠ»Π°Π·ΠΈΠΈ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ ΠΠΠ ΠΈΠ½ΠΎΠΉ. ΠΠ΅ΡΠΈΡΠΈΡ ΠΏΠ°Π»ΡΠΌΠΈΡΠΈΠ½ΠΎΠ²ΠΎΠΉ ΠΊΠΈΡΠ»ΠΎΡΡ ΠΌΠΎΠΆΠ½ΠΎ ΠΎΠ±ΡΡΡΠ½ΠΈΡΡ ΡΠΈΠ½ΡΠ΅Π·ΠΎΠΌ ΡΡΠ΅Π°ΡΠΈΠ½ΠΎΠ°ΡΠ°, ΠΊΠΎΡΠΎΡΡΠΉ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΡΡ Π² ΠΎΠ»Π΅ΠΈΠ½ΠΎΠ°Ρ.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΡΡΠ²Π»Π΅Π½Π° ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Π² ΠΏΡΠ΅Π΄Π΅Π»Π°Ρ
ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΠΎΡΠ³Π°Π½Π° ΠΈ ΠΎΠ΄Π½ΠΎΠΉ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ, ΡΡΠΎ ΠΎΡΡΠ°ΠΆΠ°Π΅Ρ ΡΡΠ°ΠΏΠ½ΠΎΡΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°
Π£ΡΠΎΠ²Π΅Π½Ρ Π½Π΅ΠΊΠΎΡΠΎΡΡΡ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΡΠ°ΠΊΠΎΠΌ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ Π² Π·Π°Π²ΠΈΡΠΈΠΌΠΎΡΡΠΈ ΠΎΡ ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΠΏΡΡ ΠΎΠ»ΠΈ
Background. Tumors influence on various vital processes in organism leading to cachexia, immunosuppression, anemia, changes in humoral regulation etc. Inflammation is one of the well-known etiological factors of carcinogenesis, including for cervical cancer, so we suggest that some blood serum inflammatory factors in patients with cervical cancer influence are associated with the level of tumor progression.The objective of our study was to analyze the level of some hematological markers of inflammation in the blood serum of patients with cervical cancer in dependence on the histological characteristics of the primary tumors.Materials and methods. In the study we analyzed the blood serum of patients with invasive cervical cancer IβIV stage (4 patients with verrucous cancer and 26 β with cervical cancer among them 10 β of G1 stage, 6 β of G2 stage, 10 β G3 stage) using flow cytometry. We studied the value of myoglobin, calprotectin, lipocalin, matrix metalloperoxidase 2, matrix metalloperoxidase 9, osteopontin, myeloperoxidase, serum amyloid A, protein 4, insulin-like growth factor-binding protein 4, cell-cell adhesion molecule 1, vascular cell adhesion molecule, cystatin Π‘.Results. We revealed the changes of some serum markers of inflammation in patients with G3 and verrocous cervical cancer.Conclusion. The obtained dates demonstrate that further study of blood inflammatory markers as an additional differential and prognostic criteria in patients with cervical cancer should be considered as reasonable.ΠΠ²Π΅Π΄Π΅Π½ΠΈΠ΅. Π‘ΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ΅ Π΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ Π½Π° ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌ ΠΏΠΎΠ΄ΡΠ°Π·ΡΠΌΠ΅Π²Π°Π΅Ρ Π²Π»ΠΈΡΠ½ΠΈΠ΅ Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ ΠΏΡΠΎΡΠ΅ΡΡΡ ΠΆΠΈΠ·Π½Π΅Π΄Π΅ΡΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΎΡΠ³Π°Π½ΠΎΠ² ΠΈ ΡΠΊΠ°Π½Π΅ΠΉ, ΠΏΡΠΈΠ²ΠΎΠ΄ΡΡΠΈΠ΅ ΠΊ ΠΊΠ°Ρ
Π΅ΠΊΡΠΈΠΈ, ΠΈΠΌΠΌΡΠ½ΠΎΠ΄Π΅ΠΏΡΠ΅ΡΡΠΈΠΈ, Π°Π½Π΅ΠΌΠΈΠΈ, ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π³ΡΠΌΠΎΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅Π³ΡΠ»ΡΡΠΈΠΈ ΠΈ Π΄Ρ. ΠΠΎΡΠΊΠΎΠ»ΡΠΊΡ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΠ΅ ΡΠ²Π»ΡΠ΅ΡΡΡ ΠΎΠ΄Π½ΠΈΠΌ ΠΈΠ· Ρ
ΠΎΡΠΎΡΠΎ ΠΈΠ·Π²Π΅ΡΡΠ½ΡΡ
ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΊΠ°Π½ΡΠ΅ΡΠΎΠ³Π΅Π½Π΅Π·Π°, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΠΈ Π΄Π»Ρ ΡΠ°ΠΊΠ° ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ (Π Π¨Π), ΠΌΡ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»Π°Π³Π°Π΅ΠΌ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΠΎΠΏΡΡ
ΠΎΠ»Π΅Π²ΠΎΠΉ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΠΈ Π½Π° ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Π² ΠΏΠ»Π°Π·ΠΌΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ Π΄Π°Π½Π½ΡΠΌ ΠΎΠ½ΠΊΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ΠΌ.Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΎΡΠ΅Π½ΠΈΡΡ ΡΡΠΎΠ²Π΅Π½Ρ ΡΡΠ΄Π° Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π Π¨Π Π² ΡΠΎΠΏΠΎΡΡΠ°Π²Π»Π΅Π½ΠΈΠΈ Ρ Π³ΠΈΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΡΠΌΠΈ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΠΎΠΏΡΡ
ΠΎΠ»ΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ°ΡΠ΅ΡΠΈΠ°Π» ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΡΡΠ²ΠΎΡΠΎΡΠΊΠ° ΠΊΡΠΎΠ²ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΠΌ Π Π¨Π IβIV ΡΡΠ°Π΄ΠΈΠΈ (4 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ Ρ Π²Π΅ΡΡΡΠΊΠΎΠ·Π½ΡΠΌ ΡΠ°ΠΊΠΎΠΌ, 26 β Ρ Π Π¨Π, ΡΡΠ΅Π΄ΠΈ ΠΊΠΎΡΠΎΡΡΡ
Ρ 10 ΡΡΠ΅ΠΏΠ΅Π½Ρ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΡΡΠΈ G1, Ρ 6 β G2, Ρ 10 β G3). ΠΠ΅ΡΠΎΠ΄ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ β ΠΏΡΠΎΡΠΎΡΠ½Π°Ρ ΡΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡ. ΠΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΠΌΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ: ΠΌΠΈΠΎΠ³Π»ΠΎΠ±ΠΈΠ½, ΠΊΠ°Π»ΡΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ½, Π»ΠΈΠΏΠΎΠΊΠ°Π»ΠΈΠ½, ΠΌΠ°ΡΡΠΈΠΊΡΠ½Π°Ρ ΠΌΠ΅ΡΠ°Π»Π»ΠΎΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·Π°-2, -9, ΠΎΡΡΠ΅ΠΎΠΏΠΎΠ½ΡΠΈΠ½, ΠΌΠΈΠ΅Π»ΠΎΠΏΠ΅ΡΠΎΠΊΡΠΈΠ΄Π°Π·Π°, ΡΡΠ²ΠΎΡΠΎΡΠΎΡΠ½ΡΠΉ Π°ΠΌΠΈΠ»ΠΎΠΈΠ΄ Π, Π±Π΅Π»ΠΎΠΊ 4, ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ ΠΈΠ½ΡΡΠ»ΠΈΠ½ΠΎΠΏΠΎΠ΄ΠΎΠ±Π½ΡΠΉ ΡΠ°ΠΊΡΠΎΡ ΡΠΎΡΡΠ°, ΠΌΠΎΠ»Π΅ΠΊΡΠ»Π° ΠΌΠ΅ΠΆΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ Π°Π΄Π³Π΅Π·ΠΈΠΈ 1, ΠΌΠΎΠ»Π΅ΠΊΡΠ»Π° Π°Π΄Π³Π΅Π·ΠΈΠΈ ΡΠΎΡΡΠ΄ΠΈΡΡΠΎΠ³ΠΎ ΡΠ½Π΄ΠΎΡΠ΅Π»ΠΈΡ 1, ΡΠΈΡΡΠ°ΡΠΈΠ½ Π‘.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΡΡΠ²Π»Π΅Π½Ρ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Ρ Π½Π΅ΠΊΠΎΡΠΎΡΡΡ
Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π² ΠΊΡΠΎΠ²ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ Π Π¨Π Π½ΠΈΠ·ΠΊΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΠΈ ΠΈ Π²Π΅ΡΡΡΠΊΠΎΠ·Π½ΡΠΌ Π Π¨Π.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ ΡΠ΅Π»Π΅ΡΠΎΠΎΠ±ΡΠ°Π·Π½ΠΎΡΡΠΈ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠ΅Π³ΠΎ ΠΈΠ·ΡΡΠ΅Π½ΠΈΡ Π°ΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ ΡΡΠΎΠ²Π½Ρ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ ΡΡΠ΄Π° Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΈ Π½Π°Π»ΠΈΡΠΈΡ Π Π¨Π Π½ΠΈΠ·ΠΊΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΡΠΎΠ²ΠΊΠΈ Π² ΡΠ΅Π»ΡΡ
ΠΈΡ
Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΠ³ΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π² ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π²ΡΠΏΠΎΠΌΠΎΠ³Π°ΡΠ΅Π»ΡΠ½ΡΡ
Π΄ΠΈΡΡΠ΅ΡΠ΅Π½ΡΠΈΠ°Π»ΡΠ½ΡΡ
ΠΈ ΠΏΡΠΎΠ³Π½ΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΊΡΠΈΡΠ΅ΡΠΈΠ΅Π²
ΠΠ·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ Π½Π΅ΠΊΠΎΡΠΎΡΡΡ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠ² ΠΌΡΠΊΠΎΠ·Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° ΠΏΠΎΠ»ΠΎΡΡΠΈ ΡΡΠ° Ρ ΡΡΠΎΠ²Π½Π΅ΠΌ Π²ΠΈΡΠ°ΠΌΠΈΠ½Π° D Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΊΠ°ΡΠΈΠ΅ΡΠΎΠΌ
Aim. To determine the saliva level of immunoregulatory proteins in patients with rampant caries and 25-hydroxyvitamin D (25(OH)D) deficiency and evaluate the association of their concentration with 25(OH)D plasma level.Materials and methods. The study was performed in two groups. The experimental group included 15 patients aged 20β22 years with rampant caries and the 25(OH)D plasma level of < 20 ng / ml. The control group encompassed 15 healthy age-matched volunteers with the 25(OH)D plasma level of 20β100 ng / ml. The concentrations of B7.2 (CD86), free active TGF-Ξ²1, CTLA-4, PD-1, Tim-3, LAG-3, IGFBP-4, and ICAM-1 were assessed using flow cytometry. The levels of LL-37 and secretory immunoglobulin A (sIgA) were measured using ELISA. The Spearmanβs rank correlation coefficient was used to reveal a correlation between the indicated proteins and the 25(OH)D plasma level.Results. A decrease in B7.2 (CD86), PD-1, Tim-3, sIgA, and LL-37 and elevation of IGFBP-4 and ICAM-1 saliva levels were detected in patients with rampant caries and 25-hydroxyvitamin D deficiency. A positive Spearmanβs rank correlation coefficient was revealed between plasma 25(OH)D and saliva levels of free active TGF-Ξ²1, CTLA4, B7.2 (CD86), LL-37, and sIgA. A negative correlation was revealed between 25(OH)Dand ICAM-1.Conclusion. 25(OH)D deficiency in patients with rampant caries is associated with decreased levels of B7.2 (CD86), PD-1, Tim-3, sIgA, and LL-37 and elevated levels of IGFBP-4 and ICAM-1 in the saliva.Β Π¦Π΅Π»Ρ β ΠΎΡΠ΅Π½ΠΈΡΡ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅Π³ΡΠ»ΡΡΠΎΡΠ½ΡΡ
ΠΌΠΎΠ»Π΅ΠΊΡΠ» Π² ΡΠ»ΡΠ½Π΅ Ρ Π»ΠΈΡ Ρ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌ ΠΊΠ°ΡΠΈΠ΅ΡΠΎΠΌ ΠΈ Π΄Π΅ΡΠΈΡΠΈΡΠΎΠΌ 25(OH)D3 ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΠΈΡΡ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·ΠΈ ΠΈΡ
Π²Π΅Π»ΠΈΡΠΈΠ½ Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠ΅ΠΉ 25(OH)D3 Π² ΠΊΡΠΎΠ²ΠΈ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ Π»ΠΈΡ Π² Π²ΠΎΠ·ΡΠ°ΡΡΠ΅ 20β22 Π»Π΅Ρ. Π ΠΎΠ΄Π½Ρ Π²ΠΊΠ»ΡΡΠ΅Π½Ρ 15 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ Ρ ΠΊΠ°ΡΠΈΠ΅ΡΠΎΠΌ ΠΈ ΡΡΠΎΠ²Π½Π΅ΠΌ 25(OH)D3 ΠΌΠ΅Π½Π΅Π΅ 20 Π½Π³/ΠΌΠ», Π² Π΄ΡΡΠ³ΡΡ (ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ) β 15 Π·Π΄ΠΎΡΠΎΠ²ΡΡ
ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ Ρ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ΠΌ 25(OH)D3 30β100 Π½Π³/ΠΌΠ». Π ΡΠΎΡΠΎΠ²ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½Ρ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΠ°ΡΡΠ²ΠΎΡΠΈΠΌΡΡ
ΡΠΎΡΠΌ ΠΌΠΎΠ»Π΅ΠΊΡΠ» B7.2 (CD86), Free Active TGF-b1, CTLA-4, PD-1, Tim-3, LAG-3, IGFBP-4, ICAM-1 ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΡΠΎΡΠΎΡΠ½ΠΎΠΉ ΡΠΈΡΠΎΡΠ»ΡΠΎΠΌΠ΅ΡΡΠΈΠΈ, ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ ΠΊΠ°ΡΠ΅Π»ΠΈΡΠΈΠ΄ΠΈΠ½Π° LL-37, ΡΠ΅ΠΊΡΠ΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π° A (IgA) ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠΌΠ΅Π½ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°. ΠΠ΅ΠΆΠ΄Ρ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ΅ΠΌΡΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ ΡΠ°ΡΡΡΠΈΡΠ°Π½ ΠΊΡΠΈΡΠ΅ΡΠΈΠΉ ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΈ Π‘ΠΏΠΈΡΠΌΠ΅Π½Π°.Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. Π£ Π»ΠΈΡ Ρ ΠΊΠ°ΡΠΈΠ΅ΡΠΎΠΌ ΠΈ Π΄Π΅ΡΠΈΡΠΈΡΠΎΠΌ Π²ΠΈΡΠ°ΠΌΠΈΠ½Π° D Π²ΡΡΠ²Π»Π΅Π½ΠΎ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΠΉ Free Active TGF-b1, B7.2 (CD86), PD-1, Tim-3, sIgA, ΠΊΠ°ΡΠ΅Π»ΠΈΡΠΈΠ΄ΠΈΠ½Π° LL-37 ΠΈ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ IGFBP-4 ΠΈ ICAM-1 Π² ΡΠ»ΡΠ½Π΅. ΠΠ±Π½Π°ΡΡΠΆΠ΅Π½ΠΎ Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΏΡΡΠΌΡΡ
ΠΊΠΎΡΡΠ΅Π»ΡΡΠΈΠΎΠ½Π½ΡΡ
ΡΠ²ΡΠ·Π΅ΠΉ ΠΌΠ΅ΠΆΠ΄Ρ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎΠΌ 25(OH)D3 Π² ΠΊΡΠΎΠ²ΠΈ, Ρ ΠΎΠ΄Π½ΠΎΠΉ ΡΡΠΎΡΠΎΠ½Ρ, ΠΈ Π·Π½Π°ΡΠ΅Π½ΠΈΡΠΌΠΈ Free Active TGF-b1, CTLA-4, Π7.2 (CD86), ΡΠ΅ΠΊΡΠ΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ IgA, ΠΏΠ΅ΠΏΡΠΈΠ΄Π° LL-37 β Ρ Π΄ΡΡΠ³ΠΎΠΉ. ΠΠ°ΡΠΈΠΊΡΠΈΡΠΎΠ²Π°Π½Π° ΠΎΡΡΠΈΡΠ°ΡΠ΅Π»ΡΠ½Π°Ρ Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ ΠΌΠ΅ΠΆΠ΄Ρ Π²Π΅Π»ΠΈΡΠΈΠ½Π°ΠΌΠΈ 25(OH)D3 ΠΈ ICAM-1.ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠ° ΡΠΎΠ½Π΅ Π΄Π΅ΡΠΈΡΠΈΡΠ° Π²ΠΈΡΠ°ΠΌΠΈΠ½Π° D ΠΏΡΠΈ ΠΌΠ½ΠΎΠΆΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΌ ΠΊΠ°ΡΠΈΠ΅ΡΠ΅ Π² ΡΠΎΡΠΎΠ²ΠΎΠΉ ΠΆΠΈΠ΄ΠΊΠΎΡΡΠΈ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΡΡΡΡΡ Π½ΠΈΠ·ΠΊΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Free Active TGF-b1, B7.2 (CD86), PD-1, Tim-3, ΡΠ΅ΠΊΡΠ΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ IgA, ΠΊΠ°ΡΠ΅Π»ΠΈΡΠΈΠ΄ΠΈΠ½Π° LL-37 ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΊΠΎΠ½ΡΡΠΎΠ»Π΅ΠΌ, Π½ΠΎ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½Ρ Π·Π½Π°ΡΠ΅Π½ΠΈΡ IGFBP-4 ΠΈ ICAM-1.